ROPIVACAINE vs ROZANOLIXIZUMAB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
ROPIVACAINE vs ROZANOLIXIZUMAB: Safety Overview
| Metric | ROPIVACAINE | ROZANOLIXIZUMAB |
|---|---|---|
| Total FAERS Reports | 2,967 | 303 |
| Deaths Reported | 150 | 9 |
| Death Rate | 5.1% | 3.0% |
| Hospitalizations | 921 | 114 |
| Average Patient Age | 50.3 yrs | 61.3 yrs |
| % Female Patients | 72.3% | 60.9% |
| FDA Approval Date | Apr 11, 2016 | N/A |
| Manufacturer | NorthStar Rx LLC | UCB, Inc. |
| Route | EPIDURAL | SUBCUTANEOUS |
| Marketing Status | Prescription | N/A |